Any explorationof the physiologyof secretionof free alpha subunit of glycoprotein hormones in humans requires a sensitive assay system that shows low cross reactivity with the intact hormones (lutropin, follitropin, thyrotropin, and choriogonadotropin). We established and validated such an assay system with a monoclonal antibody for detection of free alpha subunit in serum with better sensitivity (detection limit, 30 ng/L) and less cross reactivity (0.67% with intact human lutropin) than with available polyclonal antibody methods. Thus, the specific epitope recognized by this antibody apparently is exposed only on the free or uncombined form of alpha subunit and is concealed after non-covalent combination with any beta subunit. Using Western blot analysis, we show that most of the cross reactivity is probably the result of contamination of the human lutropin standard (obtained from the National Hormone and Pituitary Program, NIH) with small amounts of free alpha subunit. With such a specific and sensitive method, it should be possible to obtain moreprecise information regarding the secretion of free alpha subunit.
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Additional Keyphrases: cancer monitoring therapy
The pituitary glycoprotein hormones human lutropin (hLH), human follitropin (hFSH), and human thyrotropin (hTSH) are secreted as dimers comprised of noncovalently linked alpha and beta subunits (1, 2). The beta subunit confers both biological and immunological specificity to the molecule, whereas the alpha subunits of each subunit do not, being indistinguishable (3). The alpha subunit is also secreted in a free, uncombined form, released in parallel with intact hLH, and appears to be under the control of the hypothalamic hormones, gonadoliberin (GnRH) and thyroliberm (4) (5) (6) . Thus, it would appear that free alpha subunit may serve as an additional marker of GnRH-stimulated pituitary hormone release and hence a protein of value to monitor as a potential index of hypothalamic secretion. However, methods currently used to determine free alpha subunit concentrations were originally designed to measure only high concentrations of the peptide, such as those produced by certain neoplastic diseases, including pituitary adenomas (6) (7) (8) (9) , carcinoid tumors (10), and gestational trophoblastic disease (11). These previous assay methods are limited by high crossreactivity with the intact glycoprotein hormones and limited sensitivity (12 With a monoclonal antibody directed against free alpha subunit, we establishedand validated an assay method with the requisite sensitivity and specificity for measuring free alpha subunit in humans, which should prove useful in physiological studies.
MaterIals and Methods

Reagents
Purified free alpha subunit was obtained from Biomerica, The preparation and purification of free alpha subunit have been previously described (13). Briefly, the procedure is as follows. Purified hCG is dissociated with 8 mol/L urea, and the fractions are separated on a column of DEAE-Sephadex A-50. The fractions containing free alpha subunit are dialyzed repeatedly against distilled water and lyophilized before weighing.
The monoclonal antibody, whose preparation, purification, and preliminary characterization were previously described (14), was obtained from Biomerica Inc., as was 125j. labeled purified free alpha subunit. The protein used for the original immunization was the same free alpha subunit we used as the standard in the radioimmunoassay. The afilnity of this antibody for free alpha subunit, as determined by Scatchard analysis, is 2.6 x 10-10 mollL. To iodinate alphahCG we used a modified Chloramine-T method (15) . to 500 pg/100 tL. We added 100 aL of a 2400-fold dilution of alpha-subunit monoclonal antibody to each tube except those used for calculation of nonspecific binding, which instead received 100 j.tL antibody buffer: PBS containing 5 mL of normal mouse serum and 42 g of bovine serum albumin per liter. After adding 100 jzL (22 000 counts/mm) of lmIlabeled free alpha subunit (mean specific activity 180 CiJg) we vortex-mixed the contentsof all tubesand incubated them at room temperature for 24 h. We then added200 pL of an equivolume solution of PEG (280 g/L) and a 30-fold dilution of goat anti-mouse antibody to each tube. After vortex-mixing, we centrifuged the solution at 2500 x g for 30 mm, aspirated the supernates, and counted the radioactivity of the pellets with a Model 600/10 gamma counter (Micromedic, Inc., Huntsville, AL). We calculated the concentrations of the free alpha subunits with a four-parameter best-fit computer program.
Assay Specificity
To assess the specificity of the assay, we added various amounts of pure intact glycoprotein hormones to the samples and measured the bound radioactivity. Cross reactivity was determined by comparing the 50% B/B0 point on the standard curves. To determine the amount of contamination of free alpha subunit within the intact hormone preparations, we electrophoresed 7.5 pg of hormone on 10% sodium dodecyl sulfate/polyacrylamide slab gel with or without (3-mercaptoethanol (100 mLfL) reducing agent present. After 3-4 h of electrophoresis in a Bio-Rad "Protean H' system, we transferred the proteins from the gel to a nitrocellulose membrane, using a Janssen semi-dry electroblotting system, and subjected the nitrocellulose strips to general protein staining or to Western blot analysis.
Western blotting was performed on the lanes containing 
Results
Using 200 iL serum, we obtained a sensitivity of 30 ng per liter of serum for purified free alpha subunit with this assay (Figure 1) . A range of incubation times and assay temperatures was tested. Neither delaying the addition of labeled peptide to the assay tubes nor performing any portionof the assay at 4#{176}C improvedassay sensitivity below that obtained with simultaneous addition of label and antibody.
We carried out the experiments with iodinated purified free alpha subunit and with iodinated alpha-hCG.
There was no significant difference in either sensitivity or specificity of the assay between these two labels.
We calculated cross reactivities for the intact glycoproteins in the free alpha-subunit assay, with iodinated free alpha subunit as label. As shown in Figure 1 , these were 2.32% for hFSH, 0.67% for hLH, 0.36% for hTSH, and 0.09% for hCG.
We performed Western blot analysis with an alphasubunit antibody different from the one used in the radioimmunoassay because of technical difficulties with secondantibody staining of the monoclonal antibody. These results confirmed the presence of free alpha-subunit contamination within the hLH preparation ( Figure  2) . Thus, the cross reactivity of the intact glycoprotein hormones in the free alpha-subunit assay can be largely if not completely accountedfor by this contamination. We routinely used 100 pL serum in the assay. However, as shown in Figure 1 , sample volumes between 25 and 200 1zL in patients with low, normal, and supranormal concentrations of free alpha subunit gave linear results paralleling the standard curve. hntra-assay and inter-assay coefficients of variation (n = 15 assays) ranged from 2.7 to 9.2% (mean 4.2%) and 4.7 to 6.9% (mean 6.0%), respectively.Nonspecific binding ranged from 1 to 1.6% of total bound counts. We obtained nornial mean values and ranges of alpha subunit in the circulation (Table 1 ) from euthyroid individuals in the following groups: normal men <50 years of age (n = 15), normal women in the early follicular phase (days 1-5) of the menstrual cycle (n = 15), and post-menopausal women (n = 15), defined as women >50 years of age on no hormonal replacement with serum LH and FSH concentrations >60 mt.unitsfL (2nd International Reference Preparation of Gonadotropins, National hnstitute of Biological Standards and Controls, London, U.K.) and estradiol concentrations <20 ng/L.
DiscussIon
The monoclonal assay method described above displays several advantages over current polyclonal methods for the determination of free alpha subunit. ht demonstrates a significant improvement in sensitivity. With a highly pm-ifled free alpha-subunit preparation as standard, we could reliably measure alpha-subunit concentrations of 30 ng/L, a value considerably below the sensitivity of 100-300 ng/L usually achieved with existing polyclona.l (12, 16) and monoclonal methods (17, 18) . In fact, one assay system with a detection limit of 200 ng/L reports normal male alphasubunit concentrations as undetectable (18) . Perhaps the most critical improvement in tius assay system is the specificity of this antibody for the free (uncombined) alpha subunit. This antibody has nearly absolute specificity for the uncombined free alpha subunit of the glycoprotein hormones and does not recognize alpha subunit when combined with beta subunit in intact hormones. The epitopic specificity of this antibody is thus likely to be for a site on the alpha subunit that participates in its non-covalent linkage to the various beta subunits.
The small amount of cross reactivity of this antibody with intact hormones observed is consequently most likely attributable to the free alpha-subunit contamination within these preparations previously demonstrated by column chromatography (19), and confirmed by our Western blot analysis (Figure 2) . Thus, in situations where normal or even high concentrations of the intact glycoprotein hormones are present, only free alpha subunit is being measured.
We also demonstrated linearity of different sample volumes with parallelism to the standard curve, enabling reliable analysis with serum volumes between 25 and 200 p.L. This desirable feature of the assay allows samples containing low, medium, and high concentrations of alpha subunit to be run at different serum volumes within the same assay and potentially improves the assay detection limit if 200 pL of serum is used. The precision is also improved because the serum volume can be adjusted to read close to the midrange of the standard curve. This latter consideration is of particular importance in the use of this assay in studies examining pulsatile hormone secretion (20) .
The potential clinical applications of this assay system are quite diverse. Previous studies showed abnormally high concentrations of free alpha subunit in some neoplastic diseases, including pituitary tumors (6) (7) (8) (9) , carcinoid syn- alpha subunit may serve as a useful marker in monitoring the therapy of these diseases in some patients. It is important to document a normal TSH-thyroid axis in all patients when concentrations of free alpha subunit are monitored. As previously stated, TSH-secreting pituitary tumors characteristically increase the concentrations of peripheralfreealpha subunit (21) . Previous studies also documented increased free alpha subunit after administration of pharmacological doses of TEll (4, 5) and in patients with primary hypothyroidism (4, 19) . Together, these studies indicate that increase in circulating TSH, presumably under the control of TEll secretion, can influence secretion of free alpha subunit.
Our group documented an increase in free alpha-subunit secretion in response to GnRH administration 
